bearish
BioNote IPO Preview
187 Views16 Oct 2022 23:35
BioNote, a Korean company specializing in bio contents and animal diagnostics, is getting ready for an IPO in November. The IPO offering amount is from 234 billion won to 286 billion won.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Bionote: IPO Price Reduced Significantly & Bookbuilding Results13 Dec 2022
- Bionote IPO - Delayed Timeline & Updated Valuation Analysis14 Nov 2022
- BioNote IPO Valuation Analysis18 Oct 2022
- BioNote IPO Preview16 Oct 2022
- SD Biosensor (137310 KS): Aggressively Investing Windfall Gain From COVID; Adding New Growth Engines16 Oct 2022
- SD Biosensor: More Stringent Regulations for In-Vitro Diagnostics in Europe in 2022 & End of Lock-Up27 Sep 2021
- SD Biosensor IPO Valuation Analysis21 May 2021
x